Pediatric case of secondary leukemia associated with t(16;21)(q24;q22) exhibiting the chimeric AML1-MTG16 gene

被引:11
作者
Kondoh, K [1 ]
Nakata, Y [1 ]
Furuta, T [1 ]
Hosoda, F [1 ]
Gamou, T [1 ]
Kurosawa, Y [1 ]
Kinoshita, A [1 ]
Ohki, M [1 ]
Tomita, Y [1 ]
Mori, T [1 ]
机构
[1] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo 1608582, Japan
关键词
secondary leukemia; AML1-MTG16; acute promyelocytic leukemia; t(16; 21)(q24; q22);
D O I
10.1080/10428190290006242
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A chimeric gene, AML1-MTG16, showing high homology to AML1-MTG8, was recently identified in adult leukemic patients with the abnormal karyotype t(16;21)(q24;q22). We recently saw a child patient of 11 years of age who developed acute myelogenous leukemia with the karyotype t(I 6;2 l)(q24;q22), 11 months after autologous peripheral blood stem-cell transplantation (PBSCT) for acute promyelocytic leukemia with karyotype t(15;17)(q22;q11). The reciprocal translocation was localized by fluorescence in situ hybridization (FISH) analysis, reverse transcription polymerase chain reaction (RT-PCR), and Southern blot analysis of bone marrow blood cells and peripheral blood cells. FISH analysis identified a reciprocal translocation between chromosomes 16 and 21. RT-PCR analysis identified expression of the chimeric gene AML1-MTG16. Southern blot analysis revealed a breakpoint occurring at a 1.4 kb Eco RI fragment between exons 3 and 4 of MTG16. The break-point is within the same region as that of secondary leukemias, which has been reported previously. This case suggests the possibility that the region of the breakpoint of MTG16 is a characteristic of secondary leukemia.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 15 条
  • [1] Secondary acute myeloblastic leukemia with t(16;21)(q24;q22) involving the AML1 gene
    Berger, R
    LeConiat, M
    Romana, SP
    Jonveaux, P
    [J]. HEMATOLOGY AND CELL THERAPY, 1996, 38 (02): : 183 - 186
  • [2] Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites
    Broeker, PLS
    Super, HG
    Thirman, MJ
    Pomykala, H
    Yonebayashi, Y
    Tanabe, S
    ZeleznikLe, N
    Rowley, JD
    [J]. BLOOD, 1996, 87 (05) : 1912 - 1922
  • [3] Cimino G, 1997, CANCER RES, V57, P2879
  • [4] Secondary leukemias induced by topoisomerase-targeted drugs
    Felix, CA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3): : 233 - 255
  • [5] The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family
    Gamou, T
    Kitamura, E
    Hosoda, F
    Shimizu, K
    Shinohara, K
    Hayashi, Y
    Nagase, T
    Yokoyama, Y
    Ohki, M
    [J]. BLOOD, 1998, 91 (11) : 4028 - 4037
  • [6] Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO
    Gelmetti, V
    Zhang, JS
    Fanelli, M
    Minucci, S
    Pelicci, PG
    Lazar, MA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 7185 - 7191
  • [7] GU Y, 1994, CANCER RES, V54, P2326
  • [8] ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors
    Lutterbach, B
    Westendorf, JJ
    Linggi, B
    Patten, A
    Moniwa, M
    Davie, JR
    Huynh, KD
    Bardwell, VJ
    Lavinsky, RM
    Rosenfeld, MG
    Glass, C
    Seto, E
    Hiebert, SW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 7176 - 7184
  • [9] NEGRINI M, 1993, CANCER RES, V53, P4489
  • [10] Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors
    Pedersen-Bjergaard, J
    Andersen, MK
    Johansson, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1897 - 1898